Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Simponi Fungal Infection Warning Issued by FDA May 29, 2009 AboutLawsuits Add Your Comments The FDA issued a MedWatch Alert on Thursday to remind doctors about the potential side effects of Simponi, a recently-approved drug for treatment of arthritis, which can increase the risk of serious fungal infections. Delays in recognizing the infections and starting patients on antifungal treatments could result in potentially life-threatening injuries. Simponi (golimumab), which is manufactured by Centocor Ortho Biotech, Inc., is a type of medication known as a TNF-blocker. The class of medications, which also includes Enbrel (etanercept), Humira (adalimumab), Remicade (infliximab) and Cimzia (certolizumab pegol), have been associated with an increased risk of hitoplasmosis and other invasive fungal infections. The FDA approved Simponi last month for the treatment of psoriatic arthritis and ankylosing spondylitis, and a “black box” warning was placed on the drug at that time about the potential side effects, which is the strongest warning that can be placed on a prescription medication. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In September 2008, the FDA required that a “black box” warning be placed on all Tumor Necrosis Factor-alpha blocking drugs (TNF-blockers) after discovering that many doctors were failing to consistently recognize invasive fungal infections in patients treated with the drugs. Although information about the infection side effects was already contained elsewhere in the drugs warnings, they were not prominently displayed on the label. In addition to histoplasmosis, other opportunistic fungal infections associated with TNF-blockers include coccidioidomycosis, blastomycosis, candidiasis, aspergilosis and pneumocystosi. Doctors have been urged to watch for signs of potential Simponi side effects, which could resemble the flu. Symptoms could include coughing, fatigue, weight loss, sweating and shortness of breath. Over the past decade, the FDA has reported 241 cases of histoplasmosis connected to the use of TNF-blockers, with 45 of those cases resulting in death. In at least 21 cases, doctors did not recognize the fungal infection in time and delayed antifungal treatment, which led to 12 of those deaths. The cases have occurred primarily in the Mississippi River Valley and the Ohio River Valley, where the fungus is prevalent. Tags: Cimzia, Enbrel, Humira, Infection, Remicade, Simponi More Lawsuit Stories Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 July 8, 2025 Mead Johnson Must Face Enfamil NEC Lawsuit in Missouri State Court July 8, 2025 FanDuel Class Action Lawsuit Alleges Fantasy Games Constitute Illegal Sports Gambling July 8, 2025 6 Comments Gretchen November 23, 2024 My husband received his first infusion of Simponi Aria March 2024. Two weeks later he broke out in an itchy rash from head to toe. We fought it for several months. Finally told to see a dermatologist. She prescribed a strong antibiotic 500 mg four times daily but did not suspend his blood thinner. He collapsed, spent twenty-eight days in hospital, twenty units of blood, four units of plasma. Was told he was dying but survived to spend two months in rehab. This medication is a black box medication and can be very dangerous. Kevin July 6, 2023 I have been injecting Simponi for approximately 7 years with the only side effects being a mild case of oral thrush and a sensitivity to sunburn. This is the third TNF type treatment I have used for my ankylosis spondylitis and without Simponi my life would be very limited. The first TNF drug caused headaches and a severe rash. The second one didn’t work. I was also on methotrexate which caused my skin to scale so I stopped taking it. John May 10, 2019 My wife received her second infusion of simponi aria end of October 2018. Four weeks later she experienced a SEVERE outbreak of psoriasis on her legs, head, and many other parts of her body. George August 19, 2018 Few months ago my wife was administered the simponi infusion. Today. She’s laying in the ICU fighting for her life. Doctors doubt she will make it. Simponi has been identified as the major contributor to her rapidly deteriorating condition! carol January 7, 2015 I took simponi by injection for only 2 months and 5 years later I am still suffering. I got pustular psoriasis from simponi. I still have side effects from simponi. I wish I never sought help for my arthritis. As my life continues to spiral from this horrible drug. Bruce April 28, 2010 After 6 months of taking simponi i developed flue like symptoms ,rash ,sebere chills ,fever ,red/purple swollen eye ,severe skin and body pain,severe headachs .resulting in a hospital stay.they could not identify why .only after a biopsy did it show hypersencitivy .now massive doses of steroids seem to be the treatment .I lost some of my vision and still in pain ,severe fatigue ,and dizziness . I just about can take care of myself. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)